| Vasculitis and related conditions | Lifetime | 9 | IT 1 | 99.83 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 21 | IT 2 | 99.55 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 5 | IT 1 | 99.81 |
| Spondyloarthritis Studies and Treatments | Lifetime | 30 | IT 1 | 99.54 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 29 | IT 2 | 99.41 |
| Systemic Lupus Erythematosus Research | Lifetime | 142 | IT 9 | 99.42 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 17 | IT 2 | 98.87 |
| Ocular Diseases and Behçet’s Syndrome | Lifetime | 77 | IT 2 | 99.09 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 77 | IT 4 | 99.24 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 144 | IT 5 | 99.36 |
| Urticaria and Related Conditions | Lifetime | 104 | IT 10 | 98.82 |
| Renal Diseases and Glomerulopathies | Lifetime | 194 | IT 21 | 98.85 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 131 | IT 8 | 98.12 |
| Systemic Sclerosis and Related Diseases | Lifetime | 213 | IT 22 | 98.20 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 117 | IT 14 | 98.39 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 354 | IT 21 | 97.56 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 343 | IT 30 | 97.82 |
| Cell Adhesion Molecules Research | Lifetime | 987 | IT 31 | 97.32 |
| Eosinophilic Disorders and Syndromes | Lifetime | 430 | IT 41 | 96.89 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 204 | IT 15 | 97.11 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 464 | IT 57 | 96.75 |
| Retinal and Optic Conditions | Lifetime | 590 | IT 26 | 96.93 |
| Neurological Complications and Syndromes | Lifetime | 318 | IT 16 | 94.93 |
| Cerebrovascular and genetic disorders | Lifetime | 407 | IT 26 | 86.64 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 861 | IT 56 | 86.89 |
| Skin Diseases and Diabetes | Lifetime | 898 | IT 68 | 80.67 |
| Whipple's Disease and Interleukins | Lifetime | 599 | IT 32 | 62.96 |
| Vasculitis and related conditions | 2021-2025 | 36 | IT 5 | 98.28 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 158 | IT 16 | 92.18 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 211 | IT 22 | 90.87 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 84 | IT 11 | 91.13 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 434 | IT 90 | 89.08 |
| Cell Adhesion Molecules Research | 2021-2025 | 260 | IT 5 | 84.38 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 452 | IT 48 | 87.43 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 964 | IT 99 | 87.19 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 966 | IT 126 | 81.60 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 913 | IT 70 | 76.38 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 973 | IT 99 | 67.59 |
| Skin Diseases and Diabetes | 2021-2025 | 331 | IT 37 | 60.99 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 956 | IT 96 | 53.79 |
| Dermatological and COVID-19 studies | 2021-2025 | 727 | IT 143 | 51.67 |
